Microfluidic Chips: Emerging Technologies for Adoptive Cell Immunotherapy

Adoptive cell therapy (ACT) is a personalized therapy that has shown great success in treating hematologic malignancies in clinic, and has also demonstrated potential applications for solid tumors. The process of ACT involves multiple steps, including the separation of desired cells from patient tis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yishen, Hu, Rong, Du, Guangshi, Xu, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145949/
https://www.ncbi.nlm.nih.gov/pubmed/37421109
http://dx.doi.org/10.3390/mi14040877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145949/
https://www.ncbi.nlm.nih.gov/pubmed/37421109
http://dx.doi.org/10.3390/mi14040877

Ejemplares similares